This list is an analysis based on recent market events. It's not an investment recommendation.
About
Celemics, Inc. designs, manufactures, and distributes sequencing kits in South Korea. The company offers whole exome sequencing panels; NGS target enrichment panels; customized and ready-to-use enrichment panels; and modular accessories, including library preparation kits, double standard Cdna synthesis, hybridization enhancer, celan-up and streptavidin beads, CeleNM beads, and polymerase. It also provides celemics analysis, whole exome sequencing, customized NGS panels, sequencing, bioinformatics, biopharma, and custom NGS assay development services. Its products are used in oncology, liquid biopsy, biopharma solutions, inherited diseases, pharmacogenomics, virus research, agrigenomics, RNA sequencing, epigenetics, metagenomic sequencing, antibody discovery, and bioinformatics applications. The company was founded in 2010 and is headquartered in Seoul, South Korea.
The current price of 331920.KQ is ₩8,840 KRW — it has decreased by -4.23% in the past 24 hours. Watch Celemics stock price performance more closely on the chart.
What is Celemics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange Celemics stocks are traded under the ticker 331920.KQ.
Is Celemics stock price growing?▼
331920.KQ stock has risen by +2.67% compared to the previous week, the month change is a -17.15% fall, over the last year Celemics has showed a +208.01% increase.
What is Celemics market cap?▼
Today Celemics has the market capitalization of 72.17B
What is Celemics revenue for the last year?▼
Celemics revenue for the last year amounts to 5.77B KRW.
What is Celemics net income for the last year?▼
331920.KQ net income for the last year is -4.04B KRW.
How many employees does Celemics have?▼
As of November 2, 2026, the company has 40 employees.